Physician profile
Nathan M Thomas
NPI 1881044089
$1,122.32
in general payments reported to CMS, 2019-2025
17 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $90.97 · 2021: $286 · 2022: $172 · 2023: $96.61 · 2024: $232 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $573.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $191.39 | 2021-2025 | |
| Abbvie INC. | $145.87 | 2021-2025 | |
| Lilly USA, LLC | $142.71 | 2024-2025 | Mounjaro, Zepbound |
| Insulet Corporation | $88.54 | 2020-2021 | |
| Intuitive Surgical, INC. | $80.80 | 2025 | |
| Abbott Laboratories | $72.08 | 2022-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $64.04 | 2020-2024 | Ozempic |
| Ironwood Pharmaceuticals, INC | $56.30 | 2021-2022 | |
| Beta Bionics, INC. | $52.44 | 2024 | Ilet Bionic Pancreas |
| Amarin Pharma, INC. | $45.77 | 2021 | |
| Medtronic, INC. | $37.92 | 2023-2025 | Minimed 780g |
| Amgen INC. | $37.48 | 2020-2021 | |
| Vanda Pharmaceuticals INC. | $27.87 | 2025 | Fanapt, Hetlioz |
| Ascensia Diabetes Care US INC. | $24.33 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.04 | 2025 | Caplyta |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17.53 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.